A subcloned human esophageal squamous cell carcinoma cell line with low thrombomodulin expression showed increased invasiveness compared with a high thrombomodulin-expressing clone thrombomodulin as a possible candidate for an adhesion molecule of squamous cell carcinoma

Cancer Letters

Volumn 127, Issue 1-2, 1998, Pages 195-201

  Matsushita, Yoshifumi ^a   Yoshiie, Kiyotaka ^a   Imamura, Yoshiro ^a   Ogawa, Hiroki ^a   Imamura, Hiroshi ^a   Takao, Sonshinn ^a   Yonezawa, Suguru ^a   Aikou, Takashi ^a   Maruyama, Ikuro ^a   Sato, Eiichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Cell adhesion molecule; Invasion; Squamous cell carcinoma; Thrombomodulin

Indexed keywords

CELL ADHESION MOLECULE; CELL SURFACE PROTEIN; MATRIGEL; THROMBOMODULIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL GROWTH; CELL INTERACTION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ESOPHAGUS CARCINOMA; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; MOLECULAR CLONING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL SEPARATION; CLONE CELLS; ESOPHAGEAL NEOPLASMS; HUMANS; NEOPLASM INVASIVENESS; PROTEIN C; THROMBOMODULIN; TUMOR CELLS, CULTURED;

EID: 0032523739     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00038-X     Document Type: Article

References (31)

1. Esmon C.T., Esmon N.L., Harris K.W. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J. Biol. Chem. 257:1982;7944-7947.
2. Salem H.H., Maruyama I., Ishii H., Majerus P.W. Isolation and characterization of thrombomodulin from human placenta. J. Biol. Chem. 259:1984;12246-12251.
3. Maruyama I., Salem H.H., Majerus P.W. Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation. J. Clin. Invest. 74:1984;224-230.
4. Maruyama I., Salem H.H., Ishii H., Majerus P.W. Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin. J. Clin. Invest. 75:1985;987-991.
5. Maruyama I., Bell C.E., Majerus P.W. Thrombomodulin is found on endothelium of arteries, veins, capillaries and on syncytiotrophoblast of human placenta. J. Cell Biol. 101:1985;363-371.
6. Suzuki K., Kusumoto H., Deyashiki Y., Nishioka J., Maruyama I., Zushi M., Kawahara S., Honda G., Yamamoto S., Horiguchi S. Structure and expression of human thrombomodulin, a thrombin receptor of endothelium acting as a cofactor for protein C activation. EMBO J. 6:1987;1891-1897.
7. Conway E.M., Pollefeyt S., Collen D., Steiner-Mosonyi M. The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis. Blood. 89:1997;652-661.
8. Suzuki K., Nishioka J., Hayashi T., Kosaka Y. Functionally active thrombomodulin is present in human platelets. J. Biochem. 104:1988;628-632.
9. Ogura M., Ito T., Maruyama I., Takamatsu J., Yamamoto S., Ogawa K., Nagura H., Saito H. Localization and biosynthesis of functional thrombomodulin in human megakaryocytes and a human megakaryoblastic cell line (MEG-01). Thromb. Haemost. 64:1990;297-301.
10. Conway E.M., Nowakowski B., Mosonyi M.S. Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation. Blood. 80:1992;1254-1263.
11. McCachren S.S., Diggs J., Weinberg J.B., Dittman W.A. Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages. Blood. 78:1991;3128-3132.
12. Ordonez N.G. The immunohistochemical diagnosis of mesothelioma: differentiation of mesothelioma and lung adenocarcinoma. Am. J. Surg. Pathol. 13:1989;276-291.
13. Collins C.L., Ordonez N.G., Schaefer R., Cook C.D., Xie S.S., Granger J., Hsu P.L., Fink L., Hsu S.M. Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am. J. Pathol. 141:1992;827-833.
14. Tamura A., Matsubara O., Hirokawa K., Aoki N. Detection of thrombomodulin in human lung cancer cells. Am. J. Pathol. 142:1993;79-85.
15. Raife T.J., Lager D.L., Madison K.C., Piette W.W., Howard E.J., Sturm M.T., Chen Y., Lentz S.R. Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation. J. Clin. Invest. 93:1994;1846-1851.
16. Yonezawa S., Maruyama I., Sakae K., Igata A., Majerus P.W., Sato E. Thrombomodulin as a marker for vascular tumors: comparative study with factor VIII and Ulex europaeus I lectin. Am. J. Clin. Pathol. 88:1987;405-411.
17. Oikawa T., Kusuhara M., Ishikawa S., Hitomi J., Kono A., Iwanaga T., Yamaguchi K. Production of endothelin-1 and thrombomodulin by human pancreatic cancer cells. Br. J. Cancer. 69:1994;1059-1064.
18. Tezuka Y., Yonezawa S., Maruyama I., Matsushita Y., Shimizu T., Obama H., Sagara M., Shirao K., Kusano C., Natsugoe S., Yoshinaka H., Baba M., Fukumoto T., Aikou T., Sato E. Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis. Cancer Res. 55:1995;4196-4200.
19. Hamatake M., Ishida T., Mitsudori T., Akazawa K., Sugimachi K. Prognostic value and clinicopathological correlation of thrombomodulin in squamous cell carcinoma of the human lung. Clin. Cancer Res. 2:1996;763-766.
20. Nishihira T., Hashimoto Y., Katayama M., Mori S., Kuroki T. Molecular and cellular features of esophageal cancer cells. J. Cancer Res. Clin. Oncol. 119:1993;441-449.
21. Matsushita Y., Hoff S.D., Nudelman E.D., Otaka M., Hakomori S., Ota D.M., Cleary K.R., Irimura T. Metastatic behavior and cell surface properties of HT-29 human colon carcinoma variant cells selected for their differential expression of sialyl-dimeric LeX antigen. Clin. Exp. Metastasis. 9:1991;283-299.
22. Matsushita Y., Cleary K.R., Ota D.M., Hoff S.D., Irimura T. Sialyl-dimeric Lewis-X antigen expression on mucin-like glycoproteins in colorectal cancer metastases. Lab. Invest. 63:1990;780-791.
23. Repesh L.A. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis. 9:1989;192-208.
24. Schlechte W., Brattain M., Boyd D. Invasion of extracellular matrix by cultured colon cancer cells: dependence on urokinase receptor display. Cancer Commun. 2:1990;173-179.
25. Imamura H., Takao S., Aikou T. A modified invasion-3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay for quantitating tumor cell invasion. Cancer Res. 54:1994;3620-3624.
26. Imada S., Yamaguchi H., Nagumo M., Katayanagi S., Iwasaki H., Imada M. Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays. Dev. Biol. 140:1990;113-122.
27. Imada S., Yamaguchi H., Imada M. Differential expression of fetomodulin and tissue plasminogen activator to characterize parietal endoderm differentiation of F9 embryonal carcinoma cells. Dev. Biol. 141:1990;426-430.
28. Imada M., Imada S., Iwasaki H., Kume A., Yamaguchi H., Moore E.E. Fetomodulin: marker surface protein of fetal development which is modulatable by cyclic AMP. Dev. Biol. 122:1987;483-491.
29. Suehiro T., Shimada M., Matsumata T., Taketomi A., Yamamoto K., Sugimachi K. Thrombomodulin inhibits intrahepatic spread in hepatocellular carcinoma. Hepatology. 21:1995;1285-1290.
30. Yonezawa S., Tezuka Y., Matsushita Y., Saara M., Obama H., Maruyama I., Nishihira T., Aikou T., Sato E. Expression of thrombomodulin in esophageal squamous cell carcinoma cell lines. Acta Histochem. Cytochem. 29:1996;93-97.
31. Raife T.J., Demetroulis E.M., Lentz S.R. Regulation of thrombomodulin expression by All-trans retinoic acid and tumor necrosis factor-α: differential responses in keratinocytes and endothelial cells. Blood. 88:1996;2043-2049.